Month: May 2025

Bulldog’s Apparent Lack of Understanding of Tejon’s Business Risks Significant Value Destruction at Tejon Urges Shareholders to Vote “FOR” ALL of Tejon Ranch’s 10 Highly Qualified Director Nominees on the WHITE Proxy Card TEJON RANCH, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Tejon Ranch Co. (NYSE:TRC), (“Tejon” or the “Company”), a diversified real estate development and agribusiness company, today announced that it has mailed a letter to shareholders in connection with its upcoming Annual Meeting of Shareholders (the “Annual Meeting”) to be held on May 13, 2025. The full text of the letter follows: The May 13, 2025, Tejon Ranch Annual Meeting is a few weeks away. You have a critical decision to make regarding the future of your investment. Support Tejon TODAY by voting “FOR” ONLY Tejon’s highly qualified director nominees on the...

SANTA CLARA, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Silvaco Group, Inc. (Nasdaq: SVCO) (“Silvaco” or the “Company”), a provider of TCAD, EDA software and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, today announced a strategic research and development partnership with Professor Jin Jang and the Advanced Display Research Center (ADRC) at Kyung Hee University (KHU), South Korea. This four-year collaboration, which officially commenced on February 1, 2025, aims to advance display technology innovation through the integration of FTCO™ (Fab Technology Co-Optimization) with AI-driven Digital Twin modeling. Under the partnership, Silvaco will fund Ph.D. students at KHU and closely collaborate with Prof. Jang’s team to provide high-quality measurement data for emerging...

TAMPA, Fla., May 01, 2025 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced that it will explore an initiative to allocate up to 10% of future cash flows and cash reserves into cryptocurrencies and precious metals, including Bitcoin (BTC), Solana (SOL), as well as physical gold and silver. “We view that diversifying a portion of our cash management strategy into cryptocurrencies and precious metals may enhance financial resilience and create potential long-term value for our shareholders,” commented Adesh Vora Chairman of SRx Health Solutions. “We believe this strategy will not only protect our capital but also position us at the forefront of a rapidly changing economic environment and will continue to strengthen our balance sheet.” About...

Chapman Becomes Chief Executive Officer of RenasantRenasant CEO Kevin ChapmanTUPELO, Miss., May 01, 2025 (GLOBE NEWSWIRE) — Today, Renasant Corporation (the “Company”) announced that Kevin D. Chapman has officially assumed the role of Chief Executive Officer and President of both the Company and Renasant Bank (the “Bank”). C. Mitchell Waycaster, immediate past Renasant CEO, will continue as Executive Vice Chairman for both the Company and the Bank. As Executive Vice Chairman, Waycaster will continue to be involved in strategic planning, investor relations, mergers and acquisitions, and providing guidance and board level oversight for the Company. “As previously announced with our company’s succession plan, it is with full confidence and great enthusiasm that the Board and I pass the leadership torch to Kevin Chapman...

SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that the U.S. Food and Drug Administration (FDA) cleared the da Vinci Single Port (SP) surgical system for transanal local excision/resection, a form of minimally invasive surgery performed through a natural orifice to avoid abdominal surgical incisions for select procedures. This clearance extends the da Vinci SP’s capabilities in colorectal surgery, building upon procedures previously cleared by the FDA in November 2024, which include transabdominal procedures – low anterior resection, total mesorectal excision, colectomy, abdominoperineal resection, and sigmoidectomy. Intuitive engineered the da Vinci SP system to navigate in narrow...

Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer of Senti Bio discusses the positive data from lead program, SENTI-202, recently presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 Watch the “What This Means” segment here SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) — Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today announced that Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer participated in a Virtual Investor “What This Means” segment. As part of the segment, Dr. Rajangam discussed the recently announced additional positive preliminary data from a Phase 1 clinical...

VANCOUVER, British Columbia, May 01, 2025 (GLOBE NEWSWIRE) — Rio Silver Inc. (“Rio Silver” or the “Company”) (TSX.V: RYO) (OTC: RYOOF), announces that it has completed a definitive agreement (the “Option Agreement”) with Magma Silver Corp. (TSX.V: MGMA) (“Magma Silver”) for the sale (the “Transaction”) of the Niñobamba Au-Ag property (“Niñobamba” or the “Project”). Under the terms of the Option Agreement, Magma Silver has the right to earn a 100% interest in the Project upon full exercise of the option. The Option Agreement requires Magma Silver to make payments of an aggregate CAD$260,000, of which CAD$160,000 of that amount has been paid. Magma Silver will make further milestone payments of up to US$2,000,000, US$500,000 of which will constitute advanced royalty payments and will be paid over the next five years, deductible from...

PRINCETON, N.J., May 01, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing immunotherapeutic drugs targeting the tumor microenvironment (TME), today announced it will present at the 6th Annual Cytokine-Based Drug Development Summit being held May 15-16, 2025 in Boston, MA. Details of the presentation are as follows: Title: Managing Toxicity Caused by The Over Expression of Cytokines to Widen the Therapeutic WindowSession: Understanding Toxicity Challenges & Improving Safety Profiles to Widen the Therapeutic WindowSpeaker: Richard Kenney, M.D., Chief Medical Officer of Sonnet Date and Time: Thursday, May 15, 2025 at 11:15 AM ET As part of the session, Dr. Kenney will discuss:Exploring the strategy behind the...

Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) — HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company“), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced today that it has launched the MyoVista InsightsTM platform and related early adopter program for select reference sites. MyoVista Insights is a cloud-native next-generation ECG Management System designed to enhance both clinical decision-making and healthcare IT efficiency. It will integrate company developed and third-party AI-ECG algorithms as part of future releases and the current platform offers a robust set of features that streamline ECG workflows and reduce costs for healthcare providers. “I like...